Aemetis shares are trading higher after the company reported a 61% year-over-year increase in Dairy RNG production for Q4 2025 and a significant rise in biogas segment net income.

Digimarc shares are trading higher after the company reported positive non-GAAP net income and free cash flow for Q4 2025, along with expectations for significant ARR growth in 2026.

Quantum BioPharma shares are trading higher after the company announced a revised offering that includes reduced conversion prices and increased warrants, enhancing investor appeal.

ProFrac Holding Corp. shares are trading higher after the company, in partnership with Seismos, successfully deployed its fully closed-loop fracturing program, showcasing real-time optimization and significant productivity improvements.

Foghorn Therapeutics shares are trading lower after the company reported a net loss of $74.3 million for the year ended December 31, 2025. Despite securing $50 million in new financing, the significant deficit highlights ongoing financial challenges.

Harvard Bioscience shares are trading lower after reporting a decline in 2025 annual revenues to $86.6M compared to $94.1M in 2024, primarily due to a challenging global market and reduced spending by key sectors.

Frequency Electronics shares are trading lower after the company reported a decline in both revenue and net income for the third quarter and fiscal year 2026 compared to the previous year.

Stoneridge Inc. shares are trading lower after the company reported a substantial fourth-quarter net loss of $76.9 million, which was influenced by an after-tax impairment of Control Devices assets and income tax expenses related to valuation allowances.

North American Construction Group Ltd. shares are trading lower after the company reported a decrease in fourth-quarter combined revenue and gross profit, along with a sharp drop in adjusted EPS from $1.01 to -$0.14, due to cost increases and one-time project-level adjustments impacting earnings.

Vivid Seats shares are trading lower after the company reported a significant net loss of $428.7 million for the fourth quarter of 2025, marking a substantial decline from a net loss of $4.4 million in the same quarter of 2024.

Cemtrex shares are trading higher after the company announced a $1.2 million contract for its Industrial segment and reported positive revenue growth of 17% in its fiscal first quarter.

Rapid Micro Biosystems shares are trading lower after the company reported increased costs and a net loss of $12.5 million in Q4 2025 despite significant revenue growth.

Fossil Group shares are trading higher after the company reported exceeding financial performance targets for 2025 and unveiled the next evolution of its Turnaround Plan, promising stronger future growth.

Vera Bradley shares are trading higher after the company reported strong fourth-quarter results and announced key leadership appointments, signaling positive momentum in their ongoing transformation journey.

Algoma Steel Group Inc. shares are trading lower after the company reported significant financial losses for the fourth quarter of 2025, impacted by reduced shipments, high tariff costs under U.S. Section 232, and increased expenses related to its transition to electric arc furnace steelmaking.

Sleep Number shares are trading higher after the company reported exceeding sales expectations for their new ComfortMode bed and anticipated strong results from forthcoming product launches.

Village Farms shares are trading lower despite delivering record full-year profitability, as temporary supply constraints and evolving regulatory frameworks create near-term variability in performance.

G-III Apparel Group shares are trading lower after the company reported a 7% decline in net sales for Fiscal 2026, primarily due to lost sales from PVH brands and impacts from the Saks Global bankruptcy.

Precision BioSciences shares are trading higher after the company reported a strong Q4 with significant revenue growth and a positive net income turnaround. The biotech firm saw a revenue increase to $34.2 million from $0.6 million year-over-year, driven by new agreements with major partners like Novartis and Imugene, resulting in a net income of $20.1 million compared to a loss of $17.8 million the previous year.

Lifetime Brands shares are trading higher after the company reported a significant increase in operating profit and adjusted net income for Q4 2025, reflecting successful strategic decisions made to offset challenges.